Page last updated: 2024-10-22

acetazolamide and Eulenburg Disease

acetazolamide has been researched along with Eulenburg Disease in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Stunnenberg, BC2
LoRusso, S1
Arnold, WD1
Barohn, RJ1
Cannon, SC1
Fontaine, B1
Griggs, RC1
Hanna, MG1
Matthews, E1
Meola, G1
Sansone, VA1
Trivedi, JR1
van Engelen, BGM1
Vicart, S1
Statland, JM1
van Osch, T1
Sternberg, D1
Kerklaan, BJ1

Reviews

1 review available for acetazolamide and Eulenburg Disease

ArticleYear
Guidelines on clinical presentation and management of nondystrophic myotonias.
    Muscle & nerve, 2020, Volume: 62, Issue:4

    Topics: Acetazolamide; Age of Onset; Carbonic Anhydrase Inhibitors; Chloride Channels; Electrodiagnosis; Ele

2020

Other Studies

1 other study available for acetazolamide and Eulenburg Disease

ArticleYear
Prolonged attacks of weakness with hypokalemia in SCN4A-related paramyotonia congenita.
    Muscle & nerve, 2018, Volume: 58, Issue:4

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Electromyography; Humans; Hypokalemia; Male; Middle Ag

2018